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Hepatitis B virus (HBV)-X protein (HBx) is a transactivator of
host several cellular genes including alpha-fetoprotein (AFP)
which contributes to HBV associated tumor. The expression
of AFP is correlated with hepatocellular carcinoma (HCC)-
Figure 1. The effects of pcDNA3.1-HBx on the expression of AFP,
Src(60kd), Ras and CXCR4 in L-02 cells. (A) L-02 cells were transfected
with pcDNA3.1-HBx for 48a hours and the expression of HBx in L-02 cells
was evidenced by Western blotting. (B) L-02 cells were transfected with
pcDNA3.1-HBx and screened by G418, the positive clones of the cells
were selected for performing detection of objective protein. The protein
expression was evidenced by Western Blotting. The number above ﬁgure
indicates the cultured days of positive clone cells after screening by
G418. The images represent three independent experiments.
Figure 2. The effects of AFP in the expression of oncogenes in L-02
cells. (A) The expression of AFP in L-02 cells was detected after
transfecting with pcDNA3.1-HBx for 48 hours and the cells were screened
by G418; the positive cell clones (L-02-X) were selected for successive
culture for 60 days, and the AFP expressed was detected and AFP-siRNA
transfected for knockdown of the expression of AFP, Bel 7402 cells used
as a positive expression of AFP. (B) The expression of oncogenes after
knockdown of the expression of AFP in L-02-X cells. (C) The inﬂuence
of AFP on the expression of oncogenes in human liver cancer cell line,
PLC/PRF/5 (HBV-carried cells); the cells were transfected with AFP-siRNA
for 48 hours and the objective proteins were evidenced by Western
blotting. (D) The inﬂuence of AFP on the expression of oncogenes in
liver cancer cell line, Bel 7402 cells (HBV-non carried cells); the cells
were transfected with AFP-siRNA for 48 hours and the objective proteins
were evidenced by Western Blotting. The results represent at least three
repeated experiments.
initial cells. Here we perform a functional screen for host
factors involved in the transactivational properties of HBx.
We conﬁrmed HBx upregulation the expression of AFP. This
result in AFP interacted with and inhibited activity of PTEN,
these effects able to activate PI3K/AKT signal pathway to
promote the expression of Src, Ras and CXCR4 in human
liver cells line L-02. We show that PI3K inhibitors Ly294002
and interfered the expression of AFP target downstream AKT
activity and effectively repress HBx-mediated upregulation
expression of Src, Ras and CXCR4. The results indicated that
HBx driving the expression of AFP is a critical event for HBx
inducing malignant transformation of liver cells.
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Background: Nuclear factor-úB (NF-úB) plays an important
role in the development and progression of Hepatocellular
carcinoma (HCC), and especially the activation of NF-
úB induced by tumor necrosis factor-a (TNF-a) is closely
related to hepatocarcinogenesis, and is also responsible
for chemo-ressitance of HCC cells. So intervention of NF-
úB activation should be one of the important targeted
therapies of HCC. However, the mechanism and effect of
inhibiting NF-úB Activation by Anti-human Tumor Necrosis
Factor-a Monoclonal Antibody (TNF-a mAb) are still poorly
understood up to now.
Methods: In this paper, we investigate the mechanism of
NF-úB expression downregulation induced by TNF-a mAb
and the effect of TNF-a mAb on HepG2 cell cycle, apoptosis
and the expression of VEGF and P-gp.
Results: The expressions of IúBa and NF-úB in cytoplasm
were upregulated, while the level of nucleoprotein NF-
úB was obviously downregulated after given TNF-a mAb,
which were positively correlated with the decreased TNF-
a in supernatant of cell culture ﬂuid. Moreover, the copy
number of NF-úB mRNA in mAb groups were signiﬁcantly
lower than those in control. In TNF-a mAb treated HepG2
cells, the apoptotic ratio increased signiﬁcantly, and the
cell cycle changed greatly at the proportion of G1 phase,
but not at S and G2/M phase. The expressions of VEGF and
P-gp were signiﬁcantly downregulated after TNF-a mAb. The
effect of TNF-a mAb was dose- and time-dependent, which
was the most effective at the concentration of 5mg/L and
24 h point in this study.
Conclusion: Intervention of NF-úB activation pathway by
TNF-a mAb can suppress the growth of HCC cells and induce
apoptosis in vitro, which is expected to become a new
method of HCC targeted therapy.
